| ADTX | Aditxt Inc | 0.02 | -95.66% |
| LSB | LakeShore Biopharma Co Ltd | 0.03 | -94.10% |
| NTBL | Notable Labs Inc Ord | 0.03 | -92.25% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.04 | -91.79% |
| TNFA | TNF Pharmaceuticals Inc | 0.05 | -89.26% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 0.05 | -87.75% |
| AFMD | Affimed N.V. | 0.06 | -85.80% |
| EPIX | Essa Pharma Inc | 0.08 | -81.46% |
| ENLV | Enlivex Therapeutics Ltd | 0.10 | -77.84% |
| PBM | Psyence Biomedical Ltd | 0.12 | -74.00% |
| ONCO | Onconetix Inc | 0.12 | -74.00% |
| PPBT | Purple Biotech Ltd | 0.14 | -67.47% |
| ENTO | Entero Therapeutics, Inc. Common Stock | 0.15 | -65.43% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 0.16 | -64.51% |
| ONCT | Oncternal Therapeutics Inc | 0.17 | -61.48% |
| PPCB | Propanc Biopharma Inc | 0.18 | -58.18% |
| PMCB | PharmaCyte Biotech Inc | 0.21 | -52.07% |
| GLMD | Galmed Pharmaceuticals Ltd | 0.26 | -40.32% |
| APRE | Aprea Therapeutics Inc | 0.27 | -38.51% |
| NCNA | NuCana plc | 0.28 | -37.15% |
| CTXR | Citius Pharmaceuticals Inc | 0.31 | -30.37% |
| CMND | Clearmind Medicine Inc | 0.31 | -30.37% |
| AZTR | Azitra Inc | 0.32 | -28.33% |
| REVB | Revelation Biosciences Inc | 0.33 | -25.39% |
| GRI | GRI Bio Inc | 0.35 | -20.19% |
| APM | Aptorum Group Ltd - Class A | 0.36 | -18.84% |
| MGX | Metagenomi Inc | 0.37 | -15.90% |
| BOLD | Boundless Bio Inc | 0.38 | -15.00% |
| ELAB | PMGC Holdings Inc | 0.40 | -9.50% |
| ENGN | enGene Holdings Inc | 0.41 | -7.53% |
| TCRX | Tscan Therapeutics Inc | 0.42 | -5.57% |
| BRNS | Barinthus Biotherapeutics Plc. | 0.42 | -5.05% |
| VRAX | Virax Biolabs Group Ltd - Class A | 0.42 | -4.60% |
| KTTA | Pasithea Therapeutics Corp | 0.42 | -4.14% |
| OGEN | Oragenics Inc | 0.44 | -1.43% |
| SEER | Seer Inc - Class A | 0.44 | -0.98% |
| LNAI | Lunai Bioworks Inc | 0.48 | +8.74% |
| BBLG | Bone Biologics Corp | 0.48 | +8.97% |
| GNPX | Genprex Inc | 0.49 | +10.10% |
| VTGN | VistaGen Therapeutics Inc | 0.49 | +10.33% |
| GLPG | Galapagos NV | 0.49 | +11.68% |
| TIL | Instil Bio Inc | 0.50 | +12.81% |
| APVO | Aptevo Therapeutics Inc | 0.51 | +15.07% |
| BOLT | Bolt Biotherapeutics Inc | 0.51 | +16.20% |
| IMA | Ikena Oncology Inc | 0.55 | +23.89% |
| XBIT | XBiotech Inc | 0.55 | +24.12% |
| SLRN | Acelyrin Inc | 0.56 | +26.87% |
| MBIO | Mustang Bio Inc | 0.56 | +27.06% |
| FBIO | Fortress Biotech Inc | 0.56 | +27.73% |
| CDT | CDT Equity Inc | 0.57 | +28.23% |
| ACET | Adicet Bio Inc | 0.58 | +30.67% |
| BCYC | Bicycle Therapeutics Plc | 0.59 | +32.93% |
| CDIO | Cardio Diagnostics Holdings Inc | 0.60 | +35.42% |
| LITS | Lite Strategy Inc | 0.61 | +37.45% |
| ACHL | Achilles Therapeutics Plc | 0.61 | +38.13% |
| GRCE | Acasti Pharma Inc | 0.61 | +38.81% |
| MURA | Mural Oncology plc | 0.64 | +44.92% |
| VOR | Vor Biopharma Inc | 0.66 | +48.08% |
| CLDI | Calidi Biotherapeutics Inc | 0.66 | +49.66% |
| SCNI | Scinai Immunotherapeutics Ltd | 0.69 | +56.22% |
| AGIO | Agios Pharmaceuticals Inc | 0.69 | +56.67% |
| ORMP | Oramed Pharmaceuticals Inc | 0.69 | +56.90% |
| BIVI | BioVie Inc - Class A | 0.70 | +58.48% |
| DWTX | Virios Therapeutics Inc | 0.70 | +59.38% |
| HLVX | HilleVax Inc | 0.71 | +60.20% |
| PMVP | PMV Pharmaceuticals Inc | 0.72 | +63.23% |
| ACRV | Acrivon Therapeutics Inc | 0.73 | +66.17% |
| BLRX | Bioline Rx Ltd | 0.76 | +70.91% |
| ARTL | Artelo Biosciences Inc | 0.76 | +72.50% |
| INAB | IN8bio Inc | 0.77 | +74.98% |
| PEPG | PepGen Inc | 0.78 | +75.66% |
| KROS | Keros Therapeutics Inc | 0.78 | +75.66% |
| XLO | Xilio Therapeutics Inc | 0.79 | +79.28% |
| PHIO | Phio Pharmaceuticals Corp | 0.80 | +81.77% |
| LPCN | Lipocine Inc | 0.82 | +86.06% |
| NKTX | Nkarta Inc | 0.83 | +86.74% |
| GNTA | Genenta Science SpA | 0.83 | +87.87% |
| TOVX | Theriva Biologics Inc | 0.85 | +91.26% |
| BCTX | BriaCell Therapeutics Corp - New | 0.85 | +91.49% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 0.85 | +92.62% |
| DRMA | Dermata Therapeutics Inc | 0.85 | +92.84% |
| VIVS | VivoSim Labs Inc | 0.85 | +93.07% |
| ENSC | Ensysce Biosciences Inc | 0.85 | +93.30% |
| NXTC | Nextcure Inc | 0.86 | +93.52% |
| ENVB | Enveric Biosciences Inc | 0.86 | +95.10% |
| BGMS | Bio Green Med Solution Inc | 0.89 | +100.30% |
| IMRN | Immuron Ltd | 0.89 | +101.21% |
| THRD | Third Harmonic Bio Inc | 0.89 | +101.43% |
| KPRX | Kiora Pharmaceuticals Inc | 0.90 | +103.47% |
| HYPD | Eyenovia Inc | 0.91 | +106.18% |
| SAVA | Cassava Sciences Inc. | 0.92 | +108.44% |
| ATYR | Atyr Pharma Inc | 0.93 | +109.12% |
| IMMP | Immutep Ltd | 0.93 | +109.57% |
| VYNE | VYNE Therapeutics Inc | 0.93 | +109.80% |
| ADVM | Adverum Biotechnologies Inc | 0.93 | +110.25% |
| NBP | NovaBridge Biosciences. | 0.94 | +112.74% |
| MBRX | Moleculin Biotech Inc | 0.95 | +113.87% |
| RNA | Atrium Therapeutics Inc | 0.95 | +114.77% |
| JANX | Janux Therapeutics Inc | 0.95 | +115.90% |
| TRDA | Entrada Therapeutics Inc | 0.98 | +121.10% |
| CLGN | CollPlant Biotechnologies Ltd New | 0.98 | +122.46% |
| LENZ | LENZ Therapeutics Inc | 0.99 | +123.82% |
| NEUP | Neuphoria Therapeutics Inc | 0.99 | +124.27% |
| PRTC | PureTech Health plc American Depositary Shares | 1.00 | +127.21% |
| XBIO | Xenetic Biosciences Inc | 1.01 | +128.56% |
| CVAC | CureVac N.V. | 1.03 | +132.41% |
| AARD | Aardvark Therapeutics Inc | 1.03 | +133.09% |
| BNTX | BioNTech SE | 1.03 | +133.76% |
| FDMT | 4D Molecular Therapeutics Inc | 1.04 | +134.22% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | 1.05 | +137.38% |
| VERU | Veru Inc | 1.07 | +143.03% |
| ALGS | Aligos Therapeutics Inc | 1.13 | +154.79% |
| RADX | Radiopharm Theranostics Ltd | 1.13 | +155.47% |
| QNRX | Quoin Pharmaceuticals Ltd | 1.13 | +156.15% |
| ARCT | Arcturus Therapeutics Holdings Inc | 1.14 | +157.05% |
| AKTX | Akari Therapeutics Plc | 1.14 | +158.00% |
| IBIO | iBio Inc | 1.17 | +164.28% |
| SRPT | Sarepta Therapeutics Inc | 1.17 | +164.51% |
| SPRC | SciSparc Ltd | 1.19 | +168.17% |
| INTS | Intensity Therapeutics Inc | 1.19 | +169.48% |
| SABS | SAB Biotherapeutics Inc | 1.21 | +172.65% |
| ACXP | Acurx Pharmaceuticals Inc | 1.21 | +174.23% |
| INVA | Innoviva Inc | 1.22 | +175.14% |
| CURX | Curanex Pharmaceuticals Inc | 1.22 | +175.59% |
| JAGX | Jaguar Health Inc | 1.23 | +178.17% |
| BDTX | Black Diamond Therapeutics Inc | 1.24 | +180.79% |
| SILO | SILO Pharma Inc | 1.25 | +183.27% |
| SNSE | Sensei Biotherapeutics Inc | 1.26 | +185.08% |
| CVM | Cel-Sci Corp | 1.29 | +191.87% |
| CANF | Can-Fite Biopharma Ltd | 1.32 | +197.97% |
| QNCX | Quince Therapeutics Inc | 1.33 | +200.46% |
| IMUX | Immunic Inc | 1.35 | +204.53% |
| FULC | Fulcrum Therapeutics Inc | 1.36 | +207.69% |
| VYGR | Voyager Therapeutics Inc | 1.37 | +209.05% |
| CMMB | Chemomab Therapeutics Ltd | 1.38 | +211.76% |
| VNDA | Vanda Pharmaceuticals Inc | 1.39 | +213.12% |
| RCKT | Rocket Pharmaceuticals Inc | 1.39 | +213.12% |
| ATOS | Atossa Therapeutics Inc | 1.39 | +213.57% |
| RIGL | Rigel Pharmaceuticals | 1.39 | +214.25% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 1.40 | +215.38% |
| CELZ | Creative Medical Technology Holdings Inc | 1.40 | +216.06% |
| IKT | Inhibikase Therapeutics Inc | 1.40 | +216.96% |
| ADXN | Addex Therapeutics Ltd | 1.42 | +221.48% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 1.43 | +222.61% |
| LYEL | Lyell Immunopharma Inc | 1.44 | +224.65% |
| TARA | Protara Therapeutics Inc | 1.48 | +233.46% |
| ADIL | Adial Pharmaceuticals Inc | 1.48 | +233.69% |
| UPB | Upstream Bio Inc | 1.49 | +236.40% |
| ARVN | Arvinas Inc | 1.50 | +239.12% |
| OABI | OmniAb Inc | 1.50 | +239.34% |
| CLRB | Cellectar Biosciences Inc | 1.51 | +242.51% |
| CRMD | CorMedix Inc | 1.52 | +243.64% |
| LGVN | Longeveron Inc - Class A | 1.52 | +243.86% |
| RLYB | Rallybio Corp | 1.54 | +247.25% |
| MTNB | Matinas Biopharma Holdings Inc | 1.55 | +250.19% |
| SGMT | Sagimet Biosciences Inc - Class A | 1.55 | +251.55% |
| ZNTL | Zentalis Pharmaceuticals Inc | 1.56 | +252.45% |
| IPSC | Century Therapeutics Inc | 1.57 | +254.26% |
| IMRX | Immuneering Corp Class A | 1.58 | +258.33% |
| MREO | Mereo Biopharma Group Plc | 1.60 | +262.63% |
| PASG | Passage Bio Inc | 1.61 | +263.53% |
| KRRO | Korro Bio Inc | 1.61 | +265.11% |
| AVIR | Atea Pharmaceuticals Inc | 1.62 | +265.34% |
| PMN | ProMIS Neurosciences Inc | 1.62 | +266.02% |
| BMRN | Biomarin Pharmaceutical Inc | 1.63 | +268.51% |
| TNYA | Tenaya Therapeutics Inc | 1.64 | +270.09% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 1.65 | +272.51% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 1.65 | +273.84% |
| IVVD | Invivyd Inc | 1.65 | +273.93% |
| MNOV | Medicinova Inc | 1.66 | +274.16% |
| XNCR | Xencor Inc | 1.67 | +278.45% |
| ALXO | Alx Oncology Holdings Inc | 1.68 | +279.81% |
| PRTA | Prothena Corporation plc | 1.69 | +280.94% |
| MOLN | Molecular Partners AG | 1.72 | +289.53% |
| IMAB | I-Mab | 1.73 | +290.30% |
| CRIS | Curis Inc | 1.74 | +293.15% |
| LXEO | Lexeo Therapeutics Inc | 1.74 | +293.83% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1.76 | +298.12% |
| MTVA | MetaVia Inc | 1.76 | +298.80% |
| CCCC | C4 Therapeutics Inc | 1.76 | +299.03% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 1.77 | +301.06% |
| KLRS | Kalaris Therapeutics Inc | 1.80 | +308.07% |
| REPL | Replimune Group Inc | 1.81 | +308.75% |
| ERNA | Ernexa Therapeutics Inc | 1.81 | +310.10% |
| SVA | Sinovac Biotech Ltd | 1.82 | +310.56% |
| HOWL | Werewolf Therapeutics Inc | 1.82 | +311.23% |
| MRKR | Marker Therapeutics Inc | 1.82 | +312.59% |
| ZURA | Zura Bio Ltd - Class A | 1.84 | +315.53% |
| FATE | Fate Therapeutics Inc | 1.84 | +316.43% |
| ASBP | Aspire Biopharma Holdings Inc | 1.85 | +318.47% |
| ABCL | AbCellera Biologics Inc | 1.87 | +322.54% |
| GTBP | GT Biopharma Inc | 1.87 | +323.44% |
| NGNE | Neoleukin Therapeutics Inc | 1.88 | +324.80% |
| PULM | Pulmatrix Inc | 1.88 | +325.25% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | 1.90 | +330.00% |
| INMB | INmune Bio Inc | 1.91 | +331.81% |
| ATHE | Alterity Therapeutics Ltd | 1.91 | +332.03% |
| ALT | Altimmune Inc | 1.93 | +336.10% |
| SLDB | Solid Biosciences Inc | 1.93 | +336.55% |
| ANTX | AN2 Therapeutics Inc | 1.97 | +344.24% |
| GPCR | Structure Therapeutics Inc | 1.97 | +346.05% |
| VIR | Vir Biotechnology Inc | 1.98 | +348.08% |
| GRDX | Entero Therapeutics Inc | 2.00 | +351.48% |
| ICU | SeaStar Medical Holding Corp | 2.00 | +352.15% |
| HRMY | Harmony Biosciences Holdings Inc | 2.00 | +352.83% |
| ALZN | Alzamend Neuro Inc | 2.00 | +352.83% |
| CTNM | Contineum Therapeutics Inc - Class A | 2.02 | +356.00% |
| WHWK | Whitehawk Therapeutics Inc | 2.04 | +360.97% |
| CYCN | Cyclerion Therapeutics Inc | 2.05 | +362.78% |
| KAPA | Kairos Pharma Ltd | 2.05 | +364.14% |
| LBRX | LB Pharmaceuticals Inc | 2.08 | +371.37% |
| REGN | Regeneron Pharmaceuticals Inc | 2.09 | +373.41% |
| ABOS | Acumen Pharmaceuticals Inc | 2.10 | +374.08% |
| IVA | Inventiva | 2.10 | +375.44% |
| BRTX | BioRestorative Therapies Inc | 2.10 | +375.44% |
| ORIC | ORIC Pharmaceuticals Inc | 2.11 | +376.34% |
| ARMP | Armata Pharmaceuticals Inc | 2.11 | +377.02% |
| STRO | Sutro Biopharma Inc | 2.11 | +377.25% |
| EVAX | Evaxion Biotech A/S | 2.14 | +383.58% |
| TRAW | Traws Pharma Inc | 2.16 | +389.00% |
| BNTC | Benitec Biopharma Inc | 2.17 | +391.49% |
| SER | AgeX Therapeutics Inc | 2.17 | +391.72% |
| MDXG | Mimedx Group Inc | 2.22 | +402.57% |
| AVXL | Anavex Life Sciences Corporation | 2.23 | +403.02% |
| ABEO | Abeona Therapeutics Inc | 2.24 | +405.73% |
| TVRD | Cara Therapeutics Inc | 2.25 | +408.22% |
| CRBU | Caribou Biosciences Inc | 2.26 | +410.03% |
| NAUT | Nautilus Biotechnology Inc | 2.28 | +415.23% |
| DTIL | Precision Biosciences Inc | 2.29 | +417.49% |
| LRMR | Larimar Therapeutics Inc | 2.29 | +417.94% |
| FBLG | FibroBiologics Inc | 2.30 | +420.88% |
| COYA | Coya Therapeutics Inc | 2.31 | +423.14% |
| XFOR | X4 Pharmaceuticals Inc | 2.32 | +424.05% |
| OLMA | Olema Pharmaceuticals Inc | 2.32 | +424.05% |
| CMPX | Compass Therapeutics Inc | 2.32 | +425.18% |
| LEXX | Lexaria Bioscience Corp | 2.33 | +426.31% |
| ACOG | Alpha Cognition Inc | 2.35 | +430.38% |
| WVE | Wave Life Sciences Ltd | 2.38 | +438.52% |
| OVID | Ovid Therapeutics Inc | 2.39 | +440.55% |
| ALDX | Aldeyra Therapeutics Inc | 2.42 | +448.24% |
| HIND | ReShape Lifesciences Inc | 2.44 | +450.50% |
| PCVX | Vaxcyte Inc | 2.46 | +455.92% |
| PTN | Palatin Technologies Inc | 2.47 | +457.51% |
| SRZN | Surrozen Inc | 2.50 | +466.32% |
| ARTV | Artiva Biotherapeutics Inc | 2.54 | +473.78% |
| MRNA | Moderna Inc | 2.55 | +476.50% |
| TECX | AvroBio Inc | 2.55 | +477.17% |
| PLX | Protalix BioTherapeutics Inc | 2.56 | +479.89% |
| CTMX | CytomX Therapeutics Inc | 2.59 | +485.99% |
| CGEM | Cullinan Oncology Inc | 2.60 | +488.93% |
| GDTC | CytoMed Therapeutics Ltd | 2.61 | +489.83% |
| NCEL | NLS Pharmaceutics Ltd | 2.62 | +491.19% |
| PTHS | Channel Therapeutics Corporation | 2.62 | +492.55% |
| NRSN | NeuroSense Therapeutics Ltd | 2.64 | +497.52% |
| KYTX | Kyverna Therapeutics Inc | 2.65 | +498.65% |
| GOSS | Gossamer Bio Inc | 2.66 | +502.27% |
| NERV | Minerva Neurosciences Inc | 2.68 | +505.43% |
| BCAB | BioAtla Inc | 2.68 | +506.11% |
| ALLO | Allogene Therapeutics Inc | 2.69 | +507.24% |
| RZLT | Rezolute Inc | 2.69 | +508.37% |
| FTRE | FORTE SOFTWARE INC | 2.70 | +509.50% |
| IOVA | Iovance Biotherapeutics Inc | 2.70 | +510.41% |
| CRVO | CervoMed Inc | 2.72 | +515.16% |
| AIM | AIM ImmunoTech Inc. | 2.73 | +516.06% |
| ASMB | Assembly Biosciences Inc | 2.73 | +518.09% |
| CGEN | Compugen Ltd | 2.74 | +520.13% |
| TENX | Tenax Therapeutics Inc | 2.75 | +521.26% |
| IDYA | Ideaya Biosciences Inc | 2.75 | +521.26% |
| LSTA | Lisata Therapeutics Inc | 2.75 | +522.84% |
| EVMN | Evommune Inc | 2.76 | +523.75% |
| BCAX | Bicara Therapeutics Inc | 2.78 | +528.49% |
| MCRB | Seres Therapeutics Inc | 2.79 | +530.30% |
| PCSA | Processa Pharmaceuticals Inc | 2.81 | +534.82% |
| PALI | Palisade Bio Inc | 2.82 | +537.08% |
| HCWB | HCW Biologics Inc | 2.84 | +542.06% |
| CRSP | CRISPR Therapeutics AG | 2.85 | +543.19% |
| GMAB | Genmab | 2.85 | +543.42% |
| PBYI | Puma Biotechnology Inc | 2.87 | +547.94% |
| TBPH | Theravance Biopharma Inc | 2.88 | +550.42% |
| ANRO | Alto Neuroscience Inc | 2.89 | +554.27% |
| BEAM | Beam Therapeutics Inc | 2.90 | +554.72% |
| NRXP | NRX Pharmaceuticals Inc | 2.90 | +556.53% |
| ACAD | Acadia Pharmaceuticals Inc | 2.92 | +559.47% |
| CRNX | Crinetics Pharmaceuticals Inc | 2.93 | +561.50% |
| CYBN | Cybin Inc | 2.94 | +563.76% |
| IMTX | Immatics N.V | 2.95 | +567.15% |
| MLEC | Moolec Science SA | 3.00 | +577.19% |
| NTLA | Intellia Therapeutics Inc | 3.02 | +583.66% |
| MAIA | MAIA Biotechnology Inc | 3.04 | +588.18% |
| XRTX | XORTX Therapeutics Inc | 3.05 | +588.63% |
| AURA | Aura Biosciences Inc | 3.06 | +592.25% |
| CING | Cingulate Inc | 3.07 | +593.60% |
| EQ | Equillium Inc | 3.07 | +594.51% |
| CBUS | Cibus Global Ltd. Class A | 3.08 | +595.41% |
| DSGN | Design Therapeutics Inc | 3.08 | +595.86% |
| GLUE | Monte Rosa Therapeutics Inc | 3.14 | +609.20% |
| ICCC | Immucell Corp | 3.14 | +610.33% |
| ZLAB | Zai Lab Ltd | 3.17 | +617.12% |
| SPRO | Spero Therapeutics Inc | 3.20 | +623.45% |
| MNPR | Monopar Therapeutics Inc | 3.21 | +625.25% |
| OCUL | Ocular Therapeutix Inc | 3.21 | +626.84% |
| CHRS | Coherus Biosciences Inc | 3.26 | +636.33% |
| CBIO | Crescent Biopharma Inc | 3.28 | +641.76% |
| JAZZ | Jazz Pharmaceuticals plc | 3.29 | +643.57% |
| SKYE | Skye Bioscience Inc | 3.29 | +644.92% |
| ABVC | ABVC BioPharma Inc | 3.31 | +647.64% |
| ZVRA | Zevra Therapeutics Inc | 3.33 | +652.61% |
| PSTV | Plus Therapeutics Inc | 3.35 | +657.13% |
| ENTA | Enanta Pharmaceuticals Inc | 3.37 | +662.11% |
| MPLT | MapLight Therapeutics Inc | 3.38 | +663.46% |
| ADCT | Adc Therapeutics SA | 3.42 | +674.09% |
| INCY | Incyte Corp | 3.46 | +681.77% |
| MBX | MBX Biosciences Inc | 3.46 | +683.36% |
| JBIO | Jade Biosciences Inc | 3.46 | +683.36% |
| DYN | Dyne Therapeutics Inc | 3.47 | +683.81% |
| RPRX | Royalty Pharma plc - Class A | 3.47 | +685.17% |
| RLMD | Relmada Therapeutics Inc | 3.48 | +687.65% |
| ZBIO | Zenas Biopharma Inc | 3.49 | +688.78% |
| CNTB | Connect Biopharma Holdings Ltd | 3.52 | +694.89% |
| ABUS | Arbutus Biopharma Corp | 3.52 | +695.56% |
| AUPH | Aurinia Pharmaceuticals Inc | 3.52 | +696.02% |
| GERN | Geron Corp | 3.53 | +697.60% |
| CRDF | Cardiff Oncology Inc | 3.55 | +702.57% |
| CGTX | Cognition Therapeutics Inc | 3.56 | +705.06% |
| PHAR | Pharming Group N.V. | 3.59 | +710.94% |
| SEPN | Septerna Inc | 3.59 | +711.39% |
| DNLI | Denali Therapeutics Inc | 3.59 | +711.39% |
| PYXS | Pyxis Oncology Inc | 3.61 | +715.46% |
| TECH | Bio-Techne Corp | 3.61 | +716.36% |
| MESO | Mesoblast Ltd | 3.65 | +725.18% |
| NAGE | Niagen Bioscience Inc | 3.73 | +744.17% |
| IMCR | Immunocore Holdings plc | 3.75 | +747.11% |
| COCP | Cocrystal Pharma Inc | 3.75 | +748.24% |
| RANI | Rani Therapeutics Holdings Inc Class A | 3.77 | +751.18% |
| GNFT | GENFIT S.A. American Depositary Shares | 3.77 | +751.81% |
| AVTX | Avalo Therapeutics Inc | 3.78 | +754.80% |
| PRQR | ProQR Therapeutics N.V | 3.79 | +755.93% |
| CPRX | Catalyst Pharmaceuticals Inc | 3.79 | +755.93% |
| ALLR | Allarity Therapeutics Inc | 3.79 | +757.74% |
| NKTR | Nektar Therapeutics | 3.80 | +760.00% |
| NRIX | Nurix Therapeutics Inc | 3.82 | +763.39% |
| VRDN | Viridian Therapeutics Inc | 3.82 | +763.84% |
| SPRB | Spruce Biosciences Inc | 3.85 | +771.53% |
| IRON | Disc Medicine Inc | 3.86 | +772.88% |
| XENE | Xenon Pharmaceuticals Inc | 3.90 | +781.02% |
| DRUG | Bright Minds Biosciences Inc | 3.92 | +785.54% |
| RNXT | RenovoRx Inc | 3.95 | +792.78% |
| RAPP | Rapport Therapeutics Inc | 4.01 | +805.89% |
| KALA | Kala Bio Inc | 4.03 | +810.19% |
| QTTB | Q32 Bio Inc | 4.05 | +816.29% |
| MLYS | Mineralys Therapeutics Inc | 4.08 | +821.72% |
| RNAZ | TransCode Therapeutics Inc | 4.10 | +826.24% |
| CUE | Cue Biopharma Inc | 4.10 | +826.92% |
| DNTH | Dianthus Therapeutics Inc | 4.13 | +833.70% |
| ESLA | Estrella Immunopharma Inc | 4.13 | +834.38% |
| SNGX | Soligenix Inc | 4.15 | +838.90% |
| CLYM | Eliem Therapeutics Inc | 4.24 | +858.11% |
| KZIA | Kazia Therapeutics Ltd | 4.25 | +861.26% |
| MAZE | Maze Therapeutics Inc | 4.29 | +868.97% |
| EPRX | Eupraxia Pharmaceuticals Inc | 4.29 | +869.19% |
| CADL | Candel Therapeutics Inc | 4.29 | +869.19% |
| ANNX | Annexon Inc | 4.30 | +871.68% |
| IFRX | InflaRx N.V. | 4.30 | +873.04% |
| VTVT | vTv Therapeutics Inc - Class A | 4.32 | +877.65% |
| IMNM | Immunome Inc | 4.33 | +879.82% |
| AVBP | ArriVent BioPharma Inc | 4.35 | +882.53% |
| KYMR | Kymera Therapeutics Inc | 4.35 | +883.89% |
| NNVC | NanoViricides Inc | 4.36 | +884.57% |
| GRCL | Gracell Biotechnologies Inc | 4.39 | +892.70% |
| ACRS | Aclaris Therapeutics Inc | 4.45 | +906.72% |
| YMAB | Y-Mabs Therapeutics Inc | 4.46 | +908.24% |
| ETNB | 89bio Inc | 4.49 | +915.24% |
| CRVS | Corvus Pharmaceuticals Inc | 4.52 | +920.96% |
| VSTM | Verastem Inc | 4.58 | +936.11% |
| AUTL | Autolus Therapeutics plc | 4.60 | +939.50% |
| XOMA | XOMA Corp | 4.64 | +948.77% |
| APGE | Apogee Therapeutics Inc | 4.67 | +956.23% |
| SLGL | Sol-Gel Technologies Ltd | 4.67 | +956.68% |
| IGC | IGC Pharma Inc | 4.74 | +970.93% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 4.74 | +971.15% |
| ROIV | Roivant Sciences Ltd | 4.75 | +973.87% |
| TRML | Tourmaline Bio Inc | 4.77 | +977.84% |
| RLAY | Relay Therapeutics Inc | 4.77 | +977.93% |
| LXRX | Lexicon Pharmaceuticals Inc | 4.77 | +979.29% |
| ALMS | Alumis Inc | 4.81 | +987.88% |
| ADMA | Adma Biologics Inc | 4.83 | +992.63% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | 4.83 | +993.08% |
| STTK | Shattuck Labs Inc | 4.84 | +993.53% |
| MDWD | MediWound Ltd | 4.86 | +999.41% |
| NMRA | Neumora Therapeutics Inc | 4.90 | +1008.23% |
| VCEL | Vericel Corp | 4.91 | +1010.04% |
| EYPT | EyePoint Pharmaceuticals Inc | 4.94 | +1016.82% |
| UNCY | Unicycive Therapeutics Inc | 4.97 | +1023.83% |
| MIST | Milestone Pharmaceuticals Inc | 4.97 | +1024.28% |
| STOK | Stoke Therapeutics Inc | 4.98 | +1026.32% |
| TYRA | Tyra Biosciences Inc | 5.01 | +1032.65% |
| CNTX | Context Therapeutics Inc | 5.03 | +1037.17% |
| CGON | Cg Oncology Inc | 5.03 | +1037.17% |
| VERA | Vera Therapeutics Inc - Class A | 5.10 | +1052.99% |
| IMNN | Imunon Inc | 5.16 | +1066.56% |
| NUVB | Nuvation Bio Inc - Class A | 5.18 | +1071.08% |
| PRLD | Prelude Therapeutics Inc | 5.22 | +1080.12% |
| DBVT | DBV Technologies | 5.28 | +1093.69% |
| BMEA | Biomea Fusion Inc | 5.33 | +1104.99% |
| BYSI | BeyondSpring Inc | 5.38 | +1116.29% |
| CLDX | Celldex Therapeutics Inc | 5.40 | +1120.82% |
| LEGN | Legend Biotech Corp | 5.42 | +1125.34% |
| FBRX | Forte Biosciences Inc | 5.44 | +1129.86% |
| ELVN | Enliven Therapeutics Inc | 5.46 | +1134.38% |
| CDXS | Codexis Inc | 5.47 | +1136.64% |
| ABSI | Absci Corp | 5.50 | +1143.42% |
| MLTX | MoonLake Immunotherapeutics - Class A | 5.56 | +1156.99% |
| ENTX | Entera Bio Ltd | 5.62 | +1170.55% |
| GYRE | Gyre Therapeutics Inc | 5.65 | +1177.33% |
| KLTO | Klotho Neurosciences Inc Com | 5.71 | +1190.90% |
| VRTX | Vertex Pharmaceuticals Inc | 5.73 | +1195.42% |
| OBIO | Orchestra BioMed Holdings Inc | 5.77 | +1204.46% |
| TCRT | Alaunos Therapeutics Inc | 5.80 | +1211.25% |
| GHRS | GH Research PLC | 5.83 | +1218.03% |
| VANI | Vivani Medical Inc | 5.83 | +1218.03% |
| ANIX | Anixa Biosciences Inc | 5.89 | +1231.59% |
| CABA | Cabaletta Bio Inc | 5.95 | +1245.16% |
| GUTS | Fractyl Health Inc | 5.99 | +1254.20% |
| GNLX | Genelux Corp | 6.00 | +1256.46% |
| SVRA | Savara Inc | 6.06 | +1270.03% |
| RCUS | Arcus Biosciences Inc | 6.08 | +1274.55% |
| CLLS | Cellectis | 6.10 | +1279.07% |
| CAPR | Capricor Therapeutics Inc | 6.10 | +1279.07% |
| GANX | Gain Therapeutics Inc | 6.15 | +1290.37% |
| LCTX | Lineage Cell Therapeutics Inc | 6.15 | +1290.37% |
| VRCA | Verrica Pharmaceuticals Inc | 6.16 | +1292.63% |
| EVGN | Evogene Ltd | 6.18 | +1297.16% |
| NTRB | Nutriband Inc | 6.20 | +1301.68% |
| NAMS | NewAmsterdam Pharma Company NV | 6.23 | +1308.46% |
| CMRX | Chimerix Inc | 6.30 | +1323.27% |
| ONC | BeiGene Ltd | 6.33 | +1331.07% |
| EXEL | Exelixis Inc | 6.49 | +1367.24% |
| HURA | TuHURA Biosciences Inc | 6.56 | +1383.06% |
| SLN | Silence Therapeutics Plc | 6.57 | +1385.33% |
| ELDN | Eledon Pharmaceuticals Inc | 6.67 | +1407.93% |
| VALN | Valneva SE | 6.69 | +1412.45% |
| SION | Sionna Therapeutics Inc | 6.71 | +1416.98% |
| DMAC | DiaMedica Therapeutics Inc | 6.86 | +1450.89% |
| PRAX | Praxis Precision Medicines Inc | 6.96 | +1473.50% |
| ARGX | Argen X SE | 6.97 | +1475.76% |
| CALC | CalciMedica Inc | 6.98 | +1478.02% |
| SLXN | Silexion Therapeutics Corp | 7.07 | +1498.36% |
| KRYS | Krystal Biotech Inc | 7.08 | +1500.62% |
| PVLA | Palvella Therapeutics Inc | 7.14 | +1514.19% |
| OCS | Oculis Holding AG | 7.15 | +1516.45% |
| NUVL | Nuvalent Inc - Class A | 7.23 | +1534.54% |
| EWTX | Edgewise Therapeutics Inc | 7.26 | +1541.32% |
| SANA | Sana Biotechnology Inc | 7.30 | +1550.36% |
| ORKA | ARCA biopharma Inc | 7.30 | +1550.36% |
| VKTX | Viking Therapeutics Inc | 7.32 | +1554.88% |
| TARS | Tarsus Pharmaceuticals Inc | 7.34 | +1559.40% |
| ADAG | Adagene Inc | 7.36 | +1563.93% |
| TELO | Telomir Pharmaceuticals Inc | 7.38 | +1568.45% |
| TNGX | Tango Therapeutics Inc | 7.39 | +1570.71% |
| ACIU | AC Immune SA | 7.43 | +1579.75% |
| IMMX | Immix Biopharma Inc | 7.46 | +1586.53% |
| BLTE | Belite Bio Inc | 7.46 | +1586.53% |
| JSPR | Jasper Therapeutics Inc | 7.48 | +1591.06% |
| CAMP | CAMP4 Therapeutics Corp | 7.56 | +1609.14% |
| PHVS | Pharvaris NV | 7.59 | +1615.92% |
| APLT | Applied Therapeutics Inc | 7.72 | +1645.31% |
| HYFT | MindWalk Holdings Corp | 7.77 | +1656.62% |
| TLX | Telix Pharmaceuticals Ltd | 7.78 | +1658.88% |
| CAI | Caris Life Sciences Inc - Class A | 7.94 | +1695.05% |
| PRME | Prime Medicine Inc | 7.99 | +1706.35% |
| ACHV | Achieve Life Sciences Inc | 7.99 | +1706.35% |
| TSHA | Taysha Gene Therapies Inc | 8.00 | +1708.62% |
| IMVT | Immunovant Inc | 8.07 | +1724.44% |
| APLM | Apollomics Inc - Class A | 8.15 | +1742.53% |
| ATAI | ATAI Life Sciences N.V. | 8.17 | +1747.05% |
| KURA | Kura Oncology Inc | 8.42 | +1803.57% |
| OMER | Omeros Corporation | 8.44 | +1808.09% |
| CVKD | Cadrenal Therapeutics Inc | 8.56 | +1835.22% |
| FENC | Fennec Pharmaceuticals Inc | 9.19 | +1977.65% |
| AAPG | Ascentage Pharma Group International | 9.51 | +2049.99% |
| ERAS | Erasca Inc | 9.64 | +2079.38% |
| XCUR | Exicure Inc | 9.72 | +2097.47% |
| CELU | Celularity Inc - Class A | 9.89 | +2135.90% |
| LIXT | Lixte Biotechnology Holdings Inc | 10.01 | +2163.03% |
| PTGX | Protagonist Therapeutics Inc | 10.02 | +2165.29% |
| ARDX | Ardelyx Inc | 10.23 | +2212.77% |
| TGTX | TG Therapeutics Inc | 10.29 | +2226.33% |
| PYPD | Polypid Ltd | 10.44 | +2260.24% |
| QURE | uniQure N.V. | 10.62 | +2300.94% |
| COGT | Cogent Biosciences Inc | 11.13 | +2416.24% |
| ZYME | Zymeworks BC Inc | 11.15 | +2420.76% |
| CORT | Corcept Therapeutics Inc | 11.21 | +2434.32% |
| INKT | MiNK Therapeutics Inc | 11.33 | +2461.45% |
| BHVN | Biohaven Ltd | 11.91 | +2592.58% |
| TRVI | Trevi Therapeutics Inc | 11.92 | +2594.84% |
| KPTI | Karyopharm Therapeutics Inc | 12.05 | +2624.23% |
| SYRE | Spyre Therapeutics Inc | 12.16 | +2649.10% |
| SNTI | Senti Biosciences Inc | 12.20 | +2658.14% |
| BCDA | BioCardia Inc | 12.35 | +2692.05% |
| MGNX | Macrogenics Inc | 12.52 | +2730.48% |
| CNTA | Centessa Pharmaceuticals plc | 12.64 | +2757.61% |
| ACTU | Actuate Therapeutics Inc | 12.77 | +2787.00% |
| LTRN | Lantern Pharma Inc | 13.18 | +2879.69% |
| DRTS | Alpha Tau Medical Ltd | 13.19 | +2881.96% |
| OSTX | OS Therapies Inc | 13.65 | +2985.95% |
| OKYO | OKYO Pharma Ltd - New | 14.11 | +3089.95% |
| GOVX | Geovax Labs Inc | 14.14 | +3096.73% |
| ARQT | Arcutis Biotherapeutics Inc | 14.14 | +3096.73% |
| LPTX | Leap Therapeutics Inc | 14.83 | +3251.73% |
| SPRY | ARS Pharmaceuticals Inc | 15.22 | +3340.89% |
| PDSB | PDS Biotechnology Corporation | 15.27 | +3352.20% |
| NRXS | Neuraxis Inc | 15.72 | +3453.93% |
| ATNM | Actinium Pharmaceuticals Inc | 15.80 | +3472.02% |
| SLS | SELLAS Life Sciences Group Inc | 15.90 | +3494.62% |
| ATRA | Atara Biotherapeutics Inc | 16.14 | +3548.88% |
| RGNX | Regenxbio Inc | 16.41 | +3609.92% |
| INO | Inovio Pharmaceuticals Inc | 17.76 | +3915.13% |
| ARWR | Arrowhead Pharmaceuticals Inc | 18.12 | +3996.51% |
| CSBR | Champions Oncology Inc | 18.81 | +4152.51% |
| NVCT | Nuvectis Pharma Inc | 19.00 | +4195.46% |
| URGN | UroGen Pharma Ltd | 19.27 | +4256.50% |
| IPHA | Innate Pharma | 20.10 | +4444.15% |
| KOD | Kodiak Sciences Inc | 20.49 | +4532.32% |
| DYAI | Dyadic International Inc DE | 21.01 | +4649.88% |
| ABVX | Abivax | 21.18 | +4688.31% |
| HRTX | Heron Therapeutics Inc | 21.29 | +4713.18% |
| SRRK | Scholar Rock Holding Corp | 21.42 | +4742.57% |
| MTSR | Metsera Inc | 21.96 | +4864.63% |
| TLSA | Tiziana Life Sciences Ltd | 22.09 | +4894.04% |
| RVMD | Revolution Medicines Inc | 22.33 | +4948.30% |
| MDGL | Madrigal Pharmaceuticals Inc | 22.39 | +4961.86% |
| ANVS | Annovis Bio Inc | 22.61 | +5011.60% |
| ALEC | Alector Inc | 23.10 | +5122.38% |
| IRD | Ocuphire Pharma Inc | 23.82 | +5285.15% |
| HUMA | Humacyte Inc | 24.64 | +5470.54% |
| SMMT | Summit Therapeutics Inc | 24.68 | +5479.58% |
| MIRM | Mirum Pharmaceuticals Inc | 25.05 | +5563.23% |
| PHAT | Phathom Pharmaceuticals Inc | 25.37 | +5635.57% |
| ASND | Ascendis Pharma A/S | 25.62 | +5692.09% |
| TTRX | Turn Therapeutics Inc | 25.69 | +5707.92% |
| IONS | Ionis Pharmaceuticals Inc | 25.72 | +5714.70% |
| PHGE | BiomX Inc | 26.81 | +5961.12% |
| RNTX | Rein Therapeutics Inc | 28.17 | +6268.59% |
| TPST | Tempest Therapeutics Inc | 31.25 | +6964.91% |
| RNAC | Cartesian Therapeutics Inc | 31.26 | +6967.17% |
| INSM | Insmed Inc | 33.49 | +7471.32% |
| EDSA | Edesa Biotech Inc | 35.33 | +7887.30% |
| ALNY | Alnylam Pharmaceuticals Inc | 36.70 | +8197.02% |
| HALO | Halozyme Therapeutics Inc | 37.08 | +8282.93% |
| OTLK | Outlook Therapeutics Inc | 38.42 | +8585.88% |
| ANL | Adlai Nortye Ltd | 38.65 | +8638.46% |
| NVAX | Novavax Inc | 41.23 | +9221.15% |
| SNDX | Syndax Pharmaceuticals Inc | 41.75 | +9338.71% |
| TVTX | Travere Therapeutics Inc | 44.99 | +10071.20% |
| DARE | Dare Bioscience Inc | 47.97 | +10744.91% |
| KALV | KalVista Pharmaceuticals Inc | 49.03 | +10984.55% |
| RYTM | Rhythm Pharmaceuticals Inc | 51.00 | +11429.93% |
| EXOZ | Invizyne Technologies Inc | 54.63 | +12250.58% |
| CYTK | Cytokinetics Inc | 60.31 | +13534.70% |
| NBTX | Nanobiotix | 65.02 | +14599.52% |
| YDES | YD Bio Ltd | 66.53 | +14940.90% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 73.80 | +16584.48% |
| PGEN | Precigen Inc | 76.46 | +17185.84% |
| OCGN | Ocugen Inc | 80.18 | +18026.85% |
| PROK | ProKidney Corp - Class A | 100.75 | +22676.82% |
| CNSP | Cns Pharmaceuticals Inc | 106.55 | +23988.50% |
| CELC | Celcuity Inc | 122.06 | +27494.95% |
| EDIT | Editas Medicine Inc | 123.59 | +27840.85% |
| BBIO | BridgeBio Pharma Inc | 123.68 | +27861.20% |
| INDP | Indaptus Therapeutics Inc | 131.59 | +29649.47% |
| ANAB | AnaptysBio Inc | 131.64 | +29660.77% |
| ELTX | Elicio Therapeutics Inc | 132.74 | +29909.46% |
| GLSI | Greenwich LifeSciences Inc | 183.82 | +41457.47% |
| MNKD | Mannkind Corp | 187.85 | +42368.56% |
| GALT | Galectin Therapeutics Inc | 207.70 | +46856.18% |
| INBX | Inhibrx Biosciences Inc | 212.28 | +47891.62% |
| AGEN | Agenus Inc | 218.61 | +49322.68% |
| AXSM | Axsome Therapeutics Inc | 221.08 | +49881.09% |
| JUNS | Jupiter Neurosciences Inc | 227.66 | +51368.68% |
| MGTX | MeiraGTx Holdings plc | 228.30 | +51513.37% |
| RARE | Ultragenyx Pharmaceutical Inc | 247.70 | +55899.26% |
| VRNA | Verona Pharma Plc | 279.39 | +63064.23% |
| PLUR | Pluri Inc | 306.56 | +69206.15% |
| ONCY | Oncolytics Biotech Inc | 1055.04 | +238420.24% |
| PTCT | PTC Therapeutics Inc | 1743.27 | +394013.18% |
| FHTX | Foghorn Therapeutics Inc | 2005.35 | +453263.43% |